Pharmaceuticals heavyweight Novartis is changing the name of its previously indirect subsidiary AveXis to Novartis Gene Therapies. The Swiss drugmaker said the change...
06.02.2019
- Janssen, the pharmaceuticals arm of Johnson & Johnson, is once again collaborating with US clinical-stage gene therapy company MeiraGTx to develop and commercialize treatments for...
11.01.2018
- Jacobs Engineering has won a contract to complete a front-end engineering design (FEED) study for Borealis’ proposed propane dehydrogenation (PDH) unit in Belgium. The FEED phase...
27.04.2017
- Bioelectronic technologies for modulating the signaling capabilities of the nervous system could pose challenges for producers of medicinal materials and chemicals – but also for...
13.03.2017
- After acquiring the remaining stake in Bamboo Therapeutics, a privately held gene therapy group based in Chapel Hill, North Carolina, USA, last year in a drive to be a major player...
08.09.2016
- Allergan has acquired “substantially all” of the assets of RetroSense Therapeutics, a private, clinical-stage biotechnology company focused on novel gene therapy approaches to...
08.08.2016
- Pfizer has acquired the remaining stake in Bamboo Therapeutics, a privately held gene therapy group based in Chapel Hill, North Carolina, USA, in a deal that could be worth as much...
14.01.2016
- US drug firm Pfizer is linking with non-profit organization The California Institute for Biomedical Research (Calibr) to develop new heart failure treatments. Calibr said its...
